Three Generic Pharmaceutical Companies
DOJ
False Claims Act
Anti Kickback
Penalty
$447.2 million
Outcome
Three Generic Pharmaceutical Companies Agree to Pay Almost Half a Billion Dollars to Resolve Alleged False Claims Act Liability, Bringing Total Payments for Price-Fixing to Nearly $900 Million
Details
Three Generic Pharmaceutical Companies — DOJ Enforcement (2021)
Outcome: Three Generic Pharmaceutical Companies Agree to Pay Almost Half a Billion Dollars to Resolve Alleged False Claims Act Liability, Bringing Total Payments for Price-Fixing to Nearly $900 Million
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted. Crucible monitors referral patterns and financial arrangements to flag potential anti-kickback violations.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works